Netherlands: GATT Technologies raises €10.5m Series B funding

Johan Bender (left) and Geert van Gansewinkel

Medical device company GATT Technologies has closed €10.5m (US$11.4m) Series B financing led by US-based healthcare investor NGI. Johnson & Johnson Innovation – JJDC also participated along with Oost NL. At the same time, the company appointed Geert van Gansewinkel as its new chief executive officer and Vlad Hogenhuis as a new board member. Van…

You must be a HMI Subscriber to view this content.

Subscribe Now »